Barrow, Hanley, Mewhinney & Strauss’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,065,151
Closed -$86M 295
2023
Q1
$86M Sell
1,065,151
-1,205,398
-53% -$97M 0.33% 71
2022
Q4
$170M Sell
2,270,549
-118,331
-5% -$8.43M 0.64% 50
2022
Q3
$154M Sell
2,388,880
-14,503
-0.6% -$1M 0.63% 50
2022
Q2
$167M Buy
2,403,383
+194,108
+9% +$14.4M 0.63% 51
2022
Q1
$170M Buy
2,209,275
+87,039
+4% +$6.26M 0.55% 56
2021
Q4
$162M Sell
2,122,236
-397,577
-16% -$29.2M 0.51% 55
2021
Q3
$186M Buy
2,519,813
+1,642,475
+187% +$123M 0.62% 51
2021
Q2
$58.5M Buy
877,338
+418,563
+91% +$28M 0.19% 106
2021
Q1
$34.1M Sell
458,775
-250,579
-35% -$19M 0.11% 130
2020
Q4
$51.7M Sell
709,354
-141,378
-17% -$9.98M 0.18% 121
2020
Q3
$56.5M Sell
850,732
-696,996
-45% -$44.1M 0.22% 95
2020
Q2
$88.2M Buy
1,547,728
+530,577
+52% +$26M 0.35% 66
2020
Q1
$35.7M Buy
+1,017,151
New +$48.4M 0.16% 99

Other funds holding HOLX

Barrow, Hanley, Mewhinney & Strauss's HOLX Position: Q2 2023 in Review

Barrow, Hanley, Mewhinney & Strauss sold out of Hologic (HOLX) in Q2 2023, closing a stake of 1,065,151 shares — an estimated $86M sold.

Barrow, Hanley, Mewhinney & Strauss first reported a position in HOLX in Q1 2020 and held it in 13 quarters. The position peaked at $186M in Q3 2021. 713 funds tracked by Wall St. Rank hold HOLX as of Q2 2023.

  • Barrow, Hanley, Mewhinney & Strauss reported no remaining Hologic position as of Q2 2023 after selling out during the quarter.
  • Barrow, Hanley, Mewhinney & Strauss sold 1,065,151 Hologic shares in Q2 2023, an estimated $86M.
  • Barrow, Hanley, Mewhinney & Strauss first reported a position in Hologic in Q1 2020 and held it in 13 quarters.
  • Barrow, Hanley, Mewhinney & Strauss's Hologic position peaked at $186M in Q3 2021.
  • 713 funds tracked by Wall St. Rank held Hologic as of Q2 2023.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q2 2023, filed 10 Aug 2023.